FIELD: biotechnology, pharmacology. SUBSTANCE: factor b FGF (10-155) is prepared by complex formation at interaction of protective agent heparin or heparin-sulfate with b FGF (2-155) and/or b FGF (3-155) followed by enzymatic treatment of complex with pepsin A or cathepsin D. Then b FGF (10-155) is released from the complex with protective agent. EFFECT: improved method of preparing. 5 cl
Authors
Dates
1997-10-20—Published
1991-07-30—Filed